ATP13A2 variants in early-onset Parkinson's disease patients and controls

Movement Disorders

Volumn 24, Issue 14, 2009, Pages 2104-2111

  Djarmati, Ana ^a   Hagenah, Johann ^a   Reetz, Kathrin ^a   Winkler, Susen ^a   Behrens, Maria Isabel ^b   Pawlack, Heike ^a   Lohmann, Katja ^a   Ramirez, Alfredo ^c   Tadić, Vera ^a   Brüggemann, Norbert ^a   Berg, Daniela ^d   Siebner, Hartwig R ^e   Lang, Anthony E ^f   Pramstaller, Peter P ^g,h   Binkofski, Ferdinand ^a   Kostić, Vladimir S ⁱ   Volkmann, Jens ^e   Gasser, Thomas ^d   Klein, Christine ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

^c UNIVERSITY OF COLOGNE   (Germany)

^d UNIVERSITY OF TÜBINGEN   (Germany)

^e UNIVERSITY OF KIEL   (Germany)

^f TORONTO WESTERN HOSPITAL   (Canada)

^g CENTRAL HOSPITAL OF BOLZANO   (Italy)

^h INSTITUTE FOR RENEWABLE ENERGY   (Italy)

ⁱ Institute of Neurology Clinical Centre of Serbia   (Yugoslavia)

Author keywords

ATP13A2; Heterozygous changes; Neuroimaging; Parkinson's disease

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATASE 13A2; PARKIN; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; BRAIN ATROPHY; CAUCASIAN; CLINICAL FEATURE; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; EXON; FEMALE; GENETIC CODE; GENETIC VARIABILITY; GRAY MATTER; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MORPHOMETRICS; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

EID: 70450161985     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22728     Document Type: Article

References (28)

1. Ramirez A, Heimbach A, Gründemann J, et al. Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat Genet 2006;38:1184-1191. (Pubitemid 44470365)
2. Kitada T, Asakawa S, Hattori N, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998;392:605-608. (Pubitemid 28207717)
3. Valente EM, Abou-Sleiman PM, Caputo V, et al. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 2004;304:1158-1160. (Pubitemid 38661852)
4. Bonifati V, Rizzu P, van Baren MJ, et al. Mutation in DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 2003;299:256-259. (Pubitemid 36131051)
5. Di Fonzo A, Chien HF, Socal M, et al. ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease. Neurology 2007;68:1557-1562. (Pubitemid 46717978)
6. Djarmati A, Hedrich K, Svetel M, et al. Heterozygous PINK1 mutations: a susceptibility factor for Parkinson disease? Mov Disord 2006;21:1526-1530.
7. Klein C, Lohmann-Hedrich K, Rogaeva E, Schlossmacher MG, Lang AE. Deciphering the role of heterozygous mutations in genes associated with parkinsonism. Lancet Neurol 2007;6:652-662. (Pubitemid 46921058)
8. Ning YP, Kanai K, Tomiyama H, et al. PARK9-linked parkinsonism in eastern Asia: mutation detection in ATP13A2 and clinical phenotype. Neurology 2008;70:1491-1493.
9. Becker G, Berg D. Neuroimaging in basal ganglia disorder: perspectives for transcranial ultrasound. Mov Disord 2001;16:23-32. (Pubitemid 36041110)
10. Walter U, Klein C, Hilker R, Benecke R, Pramstaller PP, Dressler D. Brain parenchyma sonography detects preclinical parkinsonism. Mov Disord 2004;19:1445-1449. (Pubitemid 40104051)
11. Hagenah JM, König IR, Becker B, et al. Substantia nigra hyperechogenicity correlates with clinical status and number of Parkin mutated alleles. J Neurol 2007;254:1407-1413. (Pubitemid 350112333)
12. Schweitzer KJ, Brüssel T, Leitner P, et al. Transcranial ultrasound in different monogenetic subtypes of Parkinson's disease. J Neurol 2007;254:613-616. (Pubitemid 46781971)
13. Najim al-Din AS, Wriekat A, Mubaidin A, Dasouki M, Hiari M. Pallido-pyramidal degeneration, supranuclear upgaze paresis and dementia: Kufor-Rakeb syndrome. Acta Neurol Scand 1994;89:347-352.
14. Williams DR, Hadeed A, al-Din AS, Wreikat AL, Lees AJ. Kufor Rakeb disease: autosomal recessive, levodopa-responsive parkinsonism with pyramidal degeneration, supranuclear gaze palsy, and dementia. Mov Disord 2005;20:1264-1271.
15. Hagenah J, Hedrich K, Becker B, Pramstaller PP, Seidel G, Klein C. Distinguishing early-onset PD from dopa-responsive dystonia with transcranial sonography. Neurology 2006;66:1951-1952. (Pubitemid 44049840)
16. Binkofski F, Reetz K, Gaser C, et al. Morphometric fingerprint of asymptomatic Parkin and PINK1 mutation carriers in the basal ganglia. Neurology 2007;69:842-850. (Pubitemid 47329583)
17. Djarmati A, Guzvić M, Grünewald A, et al. Rapid and reliable detection of exon rearrangements in various movement disorders genes by multiplex ligation-dependent probe amplification. Mov Disord 2007;22:1708-1714. (Pubitemid 47597593)
18. Tang B, Xiong H, Sun P, et al. Association of PINK1 and DJ- 1confers digenic inheritance of early-onset Parkinson's disease. Hum Mol Genet 2006;15:1816-1825. (Pubitemid 43821772)
19. Dächsel JC, Mata IF, Ross OA, et al. Digenic parkinsonism: investigation of the synergistic effects of PRKN and LRRK2. Neurosci Lett 2006;410:80-84.
20. Singleton AB, Farrer M, Johnson J, et al. α-Synuclein locus triplication causes Parkinson's disease. Science 2003;302:841. (Pubitemid 37339619)
21. Marongiu R, Brancati F, Antonini A, et al. Whole gene deletion and splicing mutations expand the PINK1 genotypic spectrum. Hum Mutat 2007;28:98.
22. Brüggemann N, Odin P, Grünewald A, et al. De novo a-synuclein duplication as cause of sporadic early onset parkinsonism. Neurology 2008;71:1294.
23. Periquet M, Lucking C, Vaughan J, et al. Origin of the mutations in the parkin gene in Europe: exon rearrangements are independent recurrent events, whereas point mutations may result from Founder effects. Am J Hum Genet 2001;68:617-626. (Pubitemid 32202757)
24. Hedrich K, Eskelson C, Wilmot B, et al. Distribution, type, and origin of Parkin mutations: review and case studies. Mov Disord 2004;19:1146-1157. (Pubitemid 39429955)
25. Aharon-Peretz J, Rosenbaum H, Gershoni-Baruch R. Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews. N Engl J Med 2004;351:1972-1977. (Pubitemid 39447138)
26. Sidransky E. Heterozygosity for a Mendelian disorder as a risk factor for complex disease. Clin Genet 2006;70:275-282. (Pubitemid 44323390)
27. Berg D, Siefker C, Ruprecht-Dörfler P, Becker G. Relationship of substantia nigraechogenicity and motor function in elderly subjects. Neurology 2001;56:13-17. (Pubitemid 32059645)
28. Lasek K, Lencer R, Gaser C, et al. Morphological basis for the spectrum of clinical deficits in spinocerebellar ataxia 17 (SCA17). Brain 2006;129:2341-2352. (Pubitemid 44522119)